IMDX
Insight Molecular Diagnostics
IMDX
IMDX
33 hedge funds and large institutions have $22.5M invested in Insight Molecular Diagnostics in 2017 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 10 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.1% more ownership
Funds ownership: 0.54% → 0.64% (+0.1%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
33
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$2.53M | |
| 2 | +$511K | |
| 3 | +$485K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$269K |
| 5 |
Goldman Sachs
New York
|
+$219K |
Top Sellers
| 1 | -$6K | |
| 2 | -$5K | |
| 3 | -$4K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$1.54K |